Download Citation
Article Source:
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature
Labrecque MP,
Brown LG,
Coleman IM,
Nguyen HM,
Lin DW,
et al.
(2021)
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature.
PLOS ONE 16(1): e0245602.
https://doi.org/10.1371/journal.pone.0245602